Quest PharmaTech Inc. (QPT.V)
Develops antibody-based cancer treatments, currently testing one in pancreatic cancer patients
0.03+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-40.0%
The outlook
QPT.V is trading near the lower end of its 52-week range and sits below both its 50- and 200-day moving averages, signaling a downtrend. The stock shows minimal analyst coverage, making consensus views difficult to assess. The overall sentiment leans bearish based on current technical positioning.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range17% of the way from its 52-week low to high
Market cap
$4.2M
52-wk high
0.05
52-wk low
0.02
50-day avg
0.03
200-day avg
0.04
Trailing P/E
0.8